secwatch / observer
8-K filed December 9, 2025, 6:59 PM ET ticker PRSO CIK 0000890394
other material confidence high sentiment neutral materiality 0.30

Peraso extends Series C warrant expiration to January 7, 2026

Peraso Inc.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Peraso Inc. issued 1,293,650 shares of warrant to each holder of the Series C Warrants.

Security
warrant
Shares
1,293,650 shares
Purchaser
each holder of the Series C Warrants
Exact text from the filing
extended the expiration date of its outstanding Series C Warrants (the “Series C Warrants”) from 5:00 p.m. (New York City time) on December 5, 2025 to 5:00 p.m. (New York City time) on January 7, 2026, by entering into a third amendment with each holder of the Series C Warrants (the “Amendments”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Peraso Inc. amended Third Amendment to Series C Warrants with each holder of the Series C Warrants valued at Extended expiration date of Series C Warrants from December 5, 2025 to January 7, 2026 (effective 2025-12-05).

Action
amendment
Counterparty
each holder of the Series C Warrants
Value
Extended expiration date of Series C Warrants from December 5, 2025 to January 7, 2026
Effective
2025-12-05
Exact text from the filing
On December 5, 2025, Peraso Inc. (the “Company”) extended the expiration date of its outstanding Series C warrants (the “Series C Warrants”) from 5:00 p.m. (New York City time) on December 5, 2025 to 5:00 p.m. (New York City time) on January 7, 2026, by entering into a third amendment with each holder of the Series C Warrants (the “Amendments”).
View on SEC.gov

Browse all equity issuances →

Peraso Inc. filing history →

Source: SEC EDGAR
accession 0001213900-25-119714
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.